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Embedding of superparamagnetic iron oxide nanoparticles into
membranes of well-defined poly(ethylene oxide)-block-poly(ε-
caprolactone) nanoscale magnetovesicles as ultrasensitive MRI 
probes of membrane bio-degradation
Adeline Hannecart,a Dimitri Stanicki,a Luce Vander Elst,a Robert N. Muller,a,b Annie Brûletc, Olivier 
Sandre,d Christophe Schatz,d Sébastien Lecommandoux,d and Sophie Laurent*a,b 
The present study reports the preparation of poly(ethylene oxide)-block-poly(ε-caprolactone) (PEO-b-PCL) polymer vesicles 
via a nanoprecipitation method and the loading of two different size hydrophobically coated ultrasmall superparamagnetic 
iron oxide (USPIO) nanoparticles (magnetic core size of 4.2 nm and 7.6 nm) into the membrane of these nanovesicles, whose 
thickness was measured precisely by small angle neutron scattering (SANS). Spherical nano-assemblies with a high USPIO 
payload and a diameter close to 150 nm were obtained as confirmed by dynamic light scattering (DLS), transmission electron 
microscopy (TEM) and cryo-TEM. Vesicular structure of these hybrid nano-assemblies was confirmed by multi-angle light 
scattering (MALS) measurements. Their magnetic properties were evaluated by T1 and T2 measurements (20 and 60 MHz) 
and by nuclear magnetic relaxation dispersion (NMRD) profiles. The size of USPIO entrapped in the membranes of PEO-b-
PCL vesicles has a strong impact on their magnetic properties. It affects both their longitudinal and their transverse 
relaxivities and thus their magnetic resonance imaging (MRI) sensitivity. Acid-catalyzed hydrolysis of PCL membrane also 
influences their relaxivities as shown by measurements carried out at pH 7 vs. pH 5. This property was used to monitor the 
membrane hydrolytic degradation in vitro, as a proof of concept of potential monitoring of a drug delivery by nanomedicines 
in vivo and non-invasively, by MRI.   
Introduction
Magnetic resonance imaging (MRI) is currently a leading 
imaging modality for soft tissues and organs owing to its high 
spatial resolution, unlimited tissue penetration and non-
invasive nature. However, MRI suffers from a low sensitivity and 
requires in many cases the administration of contrast agents. In 
this context, the development of MRI contrast agents with great 
stability and high efficiency is required. The efficiency of a MRI 
contrast agent is quantified by its longitudinal (r1) and 
transverse (r2) relaxivities, defined as the increases of the 
proton nuclear relaxation rates 1/T1 and 1/T2 of the solvent 
brought by one millimole of magnetically active compound 
(such as iron or gadolinium) per litre (s-1 mM-1). Paramagnetic 
compounds are used as positive or T1-contrast agents because 
they predominantly reduce the longitudinal relaxation time of 
protons (T1) and increase the signal where they are present. On 
the contrary, ultrasmall superparamagnetic iron oxide 
nanoparticles (USPIO) are effective MRI contrast agents 
because of their very large magnetic moment. They 
predominantly reduce the transverse relaxation time of water 
protons (T2) and thus decrease the MRI signal intensity. 
Consequently they are mainly used as negative or T2-contrast 
agents [1-3].
Superparamagnetic iron oxide nanoparticles (SPION) can be 
produced by different synthetic methods carried out either in 
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Electronic Supplementary Information (ESI) available: Fig. S1: (a) 500 MHz 1H NMR spectrum of PEO45-b-PCL111 copolymer in CDCl3; (b) chromatogram of PEO45-b-PCL111 
obtained by GPC; Fig. S2: Plot of the I336/I331 ratio against the logarithm of concentration of PEO45-b-PCL111 suspensions in the presence of pyrene at fixed concentration of 
0.6 µM; Fig. S3: TEM image of PEO45-b-PCL111 polymersomes negatively stained with uranyl acetate (scale bar = 200 nm); Fig. S4: NMRD profiles of the longitudinal relaxivity 
vs. proton Larmor resonance frequency at 37°C for (a) 7.6 nm USPIO and (b) 4.2 nm USPIO; Fig. S5: Size and morphology of PEO45-b-PCL111 vesicles loaded at 32% FWR with 
iron oxide nanoparticles of 4.2 nm diameter; Fig. S6:  Multi-angle DLS plots: Variations of decay rate  versus squared scattering vector q2 measured by multi-angle DLS; Fig. 
S7: Multi-angle SLS plots:  Guinier (a,b) and Berry (c,d) plots on nanoprecipitated objects made by co-assembly of PEO45-b-PCL111 with 7.6 nm USPIOs at 16% FWR (a,c) or 
with 4.2 nm USPIOs at 32% FWR (b,d); Fig. S8:  NMRD profiles of the longitudinal relaxivity vs. proton Larmor resonance frequency at 37°C for PEO45-b-PCL111 vesicles loaded 
at 16% FWR with 7.6 nm USPIOs (circles) and at 32% FWR of 4.2 nm USPIOs (squares); Table. S1: Parameters extracted from the fitted NMRD profiles (DNMRD and MSNMRD) of 
USPIOs loaded in PEO45-b-PCL111 vesicles (in water) and individually dispersed USPIOs (in THF); Fig. S9: Intensity-weighted size distribution measured by DLS of PEO45-b-
PCL111 vesicles measured after synthesis and after magnetic chromatography; Fig. S10:  TEM image of PEO45-b-PCL111 vesicles loaded at 16% FWR with iron oxide 
nanoparticles of 7.6 nm diameter after magnetic chromatography; Table. S2: Longitudinal (r1) and transverse (r2) relaxivities (in water and at 37°C) and resultant r2/r1 ratios 
of USPIO loaded in PEO45-b-PCL111 vesicles before and after magnetic chromatography; Fig. S11: TEM images (a and b) and intensity-weighted size distributions (c and d) of 
PEO45-b-PCL111 vesicles loaded at 16% FWR with 7.6 nm iron oxide nanoparticles: a) and c) sample left 7 days at 37°C and at pH 7 and b) and d) sample left 7 days at 37°C 
and at pH 5; Fig. S12: Longitudinal relaxivities (a), transverse relaxivities (b) and transverse to longitudinal relaxivitiy ratios (c) at 20 MHz for PEO45-b-PCL111 vesicles loaded 
at 16% FWR with 7.6 nm USPIOs at pH 7 (red markers) and pH 5 (blue markers) as function of time. See DOI: 10.1039/x0xx00000x
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aqueous or organic media. A commonly used method in 
aqueous media is the iron salts alkaline coprecipitation but it 
needs precise adjustment of the experimental conditions and 
often results into a quite broad particle size distribution. A 
remarkable non-aqueous process for producing highly 
magnetized, well crystallized and monodisperse (in size and 
shape) nanoparticles is the thermal decomposition method [4, 
5]. It involves the decomposition of iron complexes in the 
presence of surfactants (oleic acid, oleylamine,…) in an organic 
solvent of high boiling temperature (>200°C). However, 
nanoparticles obtained by this way exhibit a hydrophobic layer 
and require surface modification to be transferred into aqueous 
media [6, 7]. In the recent years, several strategies have been 
developed to modify the nanoparticle surface like ligand 
addition or ligand exchange [8]. 
Another interesting way to obtain stable aqueous 
dispersions from iron oxide nanoparticles synthesized by the 
thermal decomposition method is their encapsulation via the 
self-assembly of amphiphilic block copolymers [9]. This 
approach offers the opportunity to encapsulate several USPIO 
inside a single nanoplatform, resulting in a significative increase 
of their MRI sensitivity [10-15]. Moreover, nanocarriers 
designed by the self-assembly of amphiphilic block copolymers 
can entrap both imaging and therapeutic agents, extending 
their applications to the theranostic field. Multifunctional 
nanocarriers for biomedical applications can therefore be 
assembled in this way [10, 15, 16]. As shown by Lecommandoux 
et al. [17], two main morphologies can be produced by the self-
assembly of amphililic copolymers with USPIO: 
magnetomicelles and magnetovesicles (i.e. magnetic  
polymersomes). While micelles are generally formed by the 
self-assembly of amphiphilic copolymers presenting a large 
hydrophilic part, vesicles are formed with block copolymers 
presenting a large hydrophobic part [18]. A parameter used to 
predict the morphology of the self-assembled system is the 
volume fraction of the hydrophilic block (f). As a rule of thumb, 
for PEO-based block copolymers, copolymers with fEO greater 
than 0.45 will usually induce the formation spherical micelle, 
while those with 0.40 > fEO > 0.20 will progressively form worm-
like micelles and then vesicles for the lowest hydrophilic 
fractions [19, 20]. Although the hydrophilic block fraction is an 
important parameter, the final morphology and size also 
depend on the crystallinity of the copolymer, and the 
experimental conditions used during the self-assembly process 
(temperature, addition of solvent into water or the reverse, 
mixing rate etc…).
Polymersomes are attractive nanocarriers because they can 
load hydrophilic as well as hydrophobic compounds in their 
aqueous lumen and membrane, respectively [21-26]. In 
contrast to their lipid counterparts (liposomes), they possess 
thicker membranes which make them more robust and 
facilitate the incorporation of hydrophobic nanoparticles [27]. 
Indeed, the inclusion of hydrophobic nanoparticles into 
liposome membranes can be difficult because these 
nanoparticles are usually larger than the hydrophobic bilayer 
which is typically 3-4 nm thick [28]. 
Several studies have reported the formation of 
poly(ethylene oxide)-block-poly(ε-caprolactone) (PEO-b-PCL) 
based vesicles, which are predominantly formed when fEO is 
between 12 and 28 % [29-38]. Among the different PEO-b-PCL 
formulations screened, compositions close to PEO45-b-PCL105 
(where 45 and 105 refer to the respective average degree of 
polymerization of each monomer unit) have been widely 
reported to form vesicles [29, 30, 32, 34, 35]. PEO-b-PCL 
polymersomes possess a high potential for biomedical 
applications. PEO block is biocompatible and its presence on the 
surface of nanoparticles reduces their non-specific interactions 
with plasma proteins which decrease their opsonization and 
increases their blood plasma circulation time. On the one hand, 
polymer vesicles made from PEO-based copolymers have been 
shown to remain intact and circulate for more than one day in 
rats [35]. On the other hand, PCL block is biodegradable and the 
hydrolysis of its ester linkages is accelerated in an acidic 
medium providing a controlled release of drugs at acidic pH [29, 
35]. Until now, studies on PEO-b-PCL vesicles mainly focused on 
their preparation and characterization methods and/or on the 
loading and release of drugs. However, to the best of our 
knowledge, no work has be done on the encapsulation of 
hydrophobically coated USPIOs into these nano-assemblies 
produced from PEO-b-PCL copolymers with long PCL blocks. 
In the present work, USPIOs possessing two different sizes 
(DTEM = 4.2 nm and DTEM = 7.6 nm) were synthesized by the 
thermal decomposition method and their encapsulation into 
the membranes of PEO45-b-PCL111 polymer nanovesicles is 
reported. Magnetopolymersomes obtained in this study are 
characterized by very large r2/r1 ratios (at 20 and 60 MHz), 
which makes them highly promising canditates as T2-contrast 
agents for MRI. The effect of the size of the membrane-
embedded iron oxide nanoparticles on r1 and r2 relaxivities was 
studied. Furthermore, we demonstrated for the first time in 
vitro that PCL hydrolysis in magnetopolymersome membranes 
significantly affects their magnetic relaxation properties, 
illustrating their potential to monitor PCL membrane 
degradation in vivo, which opens very promising possibilities for 
image-guided anti-cancer nanotherapies.
Experimental
Materials. 
Iron(III) acetylacetonate Fe(acac)3 (97%), oleic acid (90%), 
oleylamine (70%), benzylether (99%), tetrahydrofuran (> 99%), 
pyrene (> 99%) and iron standard for ICP (1000 ppm) were 
purchased from Sigma-Aldrich (Bornem, Belgium) and used as 
received. 1,2-hexadecanediol (> 98%) and oleyl alcohol (> 60%) 
was provided by TCI (Zwijndrecht, Belgium). Ethanol (100%) was 
purchased from Chem-Lab (Zedelgem, Belgium).
Synthesis of iron oxide nanoparticles.
Iron oxide nanoparticles were synthesized by the thermal 
decomposition method with the use of iron (III) acetylacetonate 
(Fe(acac)3) as the organometallic precursor. Two different 
organic solvents were used in order to get USPIO with two 
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different sizes, namely dibenzyl ether and a mixture of oleyl 
alcohol/dibenzyl ether (50 :50). 
Synthesis of 7.6 nm iron oxide nanoparticles. Briefly, 1, 2-
hexadecanediol (10 mmol, 2.58 g), oleic acid (2 mmol, 636 µL) 
and oleylamine (2 mmol, 658 µL) were added to dibenzyl ether 
(10 mL) in a three-neck round-bottom flask under magnetic 
stirring and a nitrogen atmosphere. This mixture was heated to 
300°C before the rapid injection of an iron precursor solution: 
Fe(acac)3 in dibenzyl ether (706 mg in 10 mL, 2 mmol). The 
reaction mixture was kept under heating at 300°C under 
magnetic stirring and nitrogen atmosphere for 30 minutes. 
After cooling down to room temperature, 40 mL of ethanol was 
added to the mixture and the black precipitate was isolated by 
magnetic decantation. The precipitate was then washed three 
times with ethanol. Finally, nanoparticles were dispersed in 40 
mL of tetrahydrofuran (THF) and the solution was centrifuged 
(16000 g, 30 minutes) to remove any undispersed material. 
Synthesis of 4.2 nm iron oxide nanoparticles. 4.2 nm iron oxide 
nanoparticles were synthesized by using a mixture of oleyl 
alcohol/dibenzyl ether (50:50) instead of dibenzyl ether as 
reaction solvent. 1, 2-hexadecanediol (10 mmol, 2.58 g) and 
oleylamine (2 mmol, 658 µL) were added to oleyl alcohol (10 
mL) in a three-neck round-bottom flask under magnetic stirring 
and a nitrogen atmosphere. This mixture was heated to 300°C 
before the rapid injection of the iron precursor solution (2 
mmol, 706 mg of Fe(acac)3 dissolved in dibenzyl ether (10 mL)). 
The reaction mixture was kept under heating at 300°C under 
magnetic stirring and a nitrogen atmosphere for 30 minutes. 
The black-coloured mixture was then cooled down to room 
temperature. Following the workup procedures described in 
the synthesis of 7.6 nm nanoparticles, a black-brown THF 
dispersion of 4.2 nm Fe3O4 nanoparticles was produced. 
Self-assembly of PEO45-b-PCL111 copolymer.
PEO45-b-PCL111 was synthesized by ring opening polymerization 
(ROP) of ɛ-caprolactone (CL) monomer in the presence of 
methyl-PEO-OH macroinitiator [40]. Nanoprecipitation of 
PEO45-b-PCL111 copolymer was carried out by dissolving the 
polymer (10 mg) in THF (500 µL). Deionized water (9 mL) was 
then added instantaneously to the THF solution under magnetic 
stirring at room temperature. The mixture was kept under 
stirring for 15 minutes. THF was removed from the aqueous 
solution by dialysis against deionized water (MWCO: 12000-
14000 gmol-1). Samples were finally sized down by extrusions 
repeated an odd number of times at 60°C through 
polycarbonate (PC) filters of diameter from 1 µm down to 100 
nm using a thermally controlled steel cylinder connected to 
pressurised nitrogen gas.
Self-assembly of PEO45-b-PCL111 with iron oxide nanoparticles.
USPIO-embedding polymersomes were prepared by co-
assembly using the same nanoprecipitation method. 
Hydrophobically coated iron oxide nanoparticles at a 
concentration in THF (500 µL) in a predetermined feed weight 
ratio (FWR) with polymer were mixed with PEO45-b-PCL111 
copolymer (10 mg). Deionized water (9 mL) was then added 
under magnetic stirring at room temperature. The mixture was 
kept under stirring for 15 minutes. Subsequently, THF was 
eliminated from the suspension by dialysis against deionized 
water (MWCO: 12000-14000 gmol-1). The suspension was 
finally gently centrifuged to remove any agglomerates and then 
downsized by an odd number of extrusion steps at 60°C through 
PC membranes using a thermally controlled steel cylinder 
connected to pressurized nitrogen gas.
Evidence of the PEO45-b-PCL111 acidolysis 
Magnetovesicle suspensions (encapsulating 7.6 nm USPIOs at 
16% FWR) were left at 37°C at pH 5.2 (Sorensen buffer) or at pH 
7.4 (PBS buffer) for a period of one week. Relaxation times were 
determined at regular intervals on aliquots. 
Similarly, empty-vesicle suspensions were left at 37°C at pH 5.2 
(Sorensen buffer) or at pH 7.4 (PBS buffer) for a period of one 
week. Aliquots taken at different times (24, 72, 144, 168, 208 
hours) were lyophilized and the resulting residues were purified 
by dialysis against deionized water (MWCO: 100-500 gmol-1) 
before lyophilisation and GPC analysis in THF.
Magnetic chromatography. 
Magnetovesicle suspensions were deposited onto a magnetic 
separation column (LS column™, Miltenyi Biotec, Leiden, The 
Netherlands) placed in a magnet. The retained vesicles were 
washed with deionized water and then retrieved after removal 
of the magnet and elution with deionized water.
Critical aggregation concentration (CAC) determination. 
The CAC of the copolymer in aqueous medium was determined 
by a fluorescence technique using pyrene as a nonpolar probe. 
Pyrene solution in acetone (4.8 × 10-5 M, 50 µL) was added to 4 
mL of aqueous polymer solutions at different concentrations. 
The obtained samples were stirred for 48 h at room 
temperature to allow evaporation of acetone. The resulting 
samples possess a constant pyrene concentration of 0.6 µM. 
Fluorescence spectra were recorded on a spectrofluorometer 
(LS 55, PerkinElmer, Waltham (MA), USA) at a scanning rate of 
50 nm/min at room temperature; the slit widths were set at 2.5 
nm. Excitation spectra of pyrene were recorded in the range 
300-360 nm with the emission wavelength set at 371 nm. The 
CAC was estimated as the cross point of straight lines obtained 
at low and high concentration regions by plotting the intensity 
ratio I336/I331 against the logarithmic concentration of the 
copolymer [41].
Instrumentation. 
Dynamic light scattering (DLS) measurements were conducted 
at 20°C on a Zetasizer NanoZS ZEN 3600 instrument (Malvern, 
UK) to measure the hydrodynamic diameters (DH) and 
polydispersity index (PDIDLS). Reported DH and PDIDLS values 
were measured in triplicate from the 2nd order cumulant fit of 
the correlograms obtained from the backscattered light 
intensity at 173° scattering angle.
Multi-angle DLS and static light scattering (SLS) studies were 
performed with an ALV/CGS-3 compact laser goniometer 
equipped with a 632.8 nm HeNe laser (4 mW) and an ALV-
5000/EPP multi tau digital correlator. Measurements were 
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carried out over an angle range from 40° to 140° in 10° stepwise 
increments. A cylindrical glass cell containing 1 mL of the sample 
was immersed in a filtered toluene bath, whose background 
signal was measured at all angles for Rayleigh ratio 
determination. Refractive index increment (dn/dc) was 
determined with a gel permeation chromatography (GPC) 
system equipped with a refractometer detector. Suspensions of 
copolymer co-assembled with IONPs at constant FWR and 
different total concentrations c were analysed and a linear fit 
yielded the value of dn/dc. For multi-angle DLS experiments, the 
CONTIN fit introduced by Provencher [42] was applied on the 
autocorrelograms to obtain the decomposition into decay rate 
modes i without any assumption on their number. Then i 
values were plotted versus the square of the light scattering 
vector q=4nsin(/2)/ where n is the solvent refraction index,  
the wavelength and  the scattering angle in order to get the 
corresponding translational diffusion constants, converted into 
hydrodynamic diameters using Stokes-Einstein’s relationship. 
Transmission electron microscopy (TEM) images were 
recorded on a Microscope Fei Tecnai 10 operating at an 
accelerating voltage of 80 kV (Oregon, USA). For USPIO samples, 
a drop of diluted suspension ([Fe] ≈ 0.5 mM) in THF was placed 
on a carbon-coated copper grid (300 mesh). Images were 
analysed using automated particle counting of ImageJ software 
after thresholding and watershed filtering, enabling to perform 
a statistical treatment of the diameters. Based on a minimum of 
1000 nanoparticles per batch, the polydispersity index (PDITEM) 
was calculated using the following equations, by analogy with 
dispersity (Ð) defined for polymer chains, but subtracting 1 to 
obtain a PDI below 1 (like in DLS):
n
wTEM
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and  are the number-average and the weight-average nD wD
diameters, respectively, and ni the number of nanoparticles of 
diameter Di.
For empty vesicles (pure PEO-b-PCL nanoprecipitated 
copolymer), negatively stained TEM images were acquired by 
placing successively a drop of diluted suspension (2 minutes), a 
drop of phosphate-buffered saline (pH 7.4) (2 minutes), a drop 
of DI water (2 minutes) and a drop of uranyl acetate 2% (w/v) 
solution (10 minutes) on a carbon-coated copper grid (300 
mesh). Surplus of solutions were removed before each grid 
transfer. TEM images of vesicles loaded with USPIOs were 
obtained on grids prepared by placing a drop of diluted 
suspension ([Fe] ≈ 0.1 mM) on a Formvar™-coated copper grid 
(300 mesh).
Cryo-TEM images were recorded at the Institut de Physique 
et Chimie des Matériaux of Strasbourg (IPCMS, Pr. O. Ersen and 
D. Ihiawakrim) on a Microscope JEOL 2100 F operating at an 
accelerating voltage of 200 kV. A drop of diluted suspension was 
placed on a carbon-coated copper grid (300 mesh), which was 
beforehand treated with an ELMO glow discharge unit 
(Cordouan Technologies, Pessac, France) to render the surface 
hydrophilic. The drop size was reduced with a filter paper until 
having a thin film. The grid was then plunged into liquid nitrogen 
and subsequently in liquid ethane. Maintained at a temperature 
near liquid nitrogen temperature (-190°C), the grid was 
transferred to a cryo-holder which was introduced into the 
high-vacuum column of the microscope.
Small angle neutron scattering (SANS) measurements were 
performed on the PACE spectrometer of Laboratoire Leon 
Brillouin (CEA-Saclay, France). Three configurations were used 
by varying the sample to detector distance and the neutrons 
wavelength () in order to cover a large q range: 3.18 10-3 – 3.70 
10-1 A-1. The samples were prepared in pure heavy water (pure 
copolymer) or in a mixture of 20% v/v D2O and H2O, matching 
the theoretical neutron scattering length density (SLD) of the 
PCL blocks for those loaded with iron oxide NPs, in quartz 
cuvettes of respective thicknesses 2 mm or 1 mm. The 
scattering curves were divided by the transmission factor and 
by the thickness after subtracting the signal of an empty 
cuvette. Correction of the efficacy of the detector was 
performed by normalizing the curves by the signal of a 1 mm 
cuvette filled with light water to obtain the scattering intensity, 
I(q), in absolute value (cm-1) [43].
Dosage of iron was performed by Inductively Coupled 
Plasma-Atomic Emission Spectroscopy (ICP-AES) on a Jobin 
Yvon JY70C instrument (Longjumeau, France). The total amount 
of iron was determined after microwave digestion (Milestone 
MLS-1200 MEGA, Gemini B.V., Apeldoorn, the Netherlands) in a 
mixture of nitric acid (600 µL, 65 %) and hydrogen peroxide (300 
µL, 35%). An iron standard solution for ICP (1000 mgmL-1 of iron 
in nitric acid) was used to obtain a calibration curve (linear 
correlation coefficient = 0.99).
Molecular weight distribution of the copolymers was 
measured by gel permeation chromatography (GPC) analysis 
(Agilent 1200 apparatus) equipped with a differential refractive 
index detector. Sample solutions (1 mg/mL in THF, 2% NEt3) 
were injected with a 1 mLmin-1 flow rate at 35°C, in a pre-
column PLgel 10 µm (50  7.5 mm) and in two gradient columns 
PLgel 10 µm mixed-B (300  7,5mm) (Laboratory of Polymeric 
and Composite Materials, Pr. P. Dubois, UMonS). Additional 
GPC analyses of PCL block hydrolysis as a function of time and 
pH were performed with THF as eluent on an UltiMate 3000 
system from Thermo Fisher Scientific equipped with a diode 
array detector (DAD), a multi-angle light scattering (MALS) 
detector and a differential refractive index (dRI) detector from 
Wyatt Technology Corp. (Toulouse, France). Polymers were 
separated on three G2000, G3000 and G4000 TOSOH HXL gel 
columns (300  7.8 mm) (size exclusion limits from 1000 to 400 
000 gmol-1) held at 40°C and under a THF flowrate of 1 mL/min. 
EasiVial™ kit of Polystyrene from Agilent was used as the Mn 
calibration standard (from 162 to 364 000 gmol-1).
Nuclear magnetic resonance (NMR) spectrum was recorded 
on a Bruker Avance 500 MHz spectrometer (Karlsruhe, 
Germany). DOSY-NMR measurements were conducted using a 
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STE-LED (stimulated echo-longitudinal eddy current delay) 
standard sequence with a diffusion time (Δ) of 250 ms, a 
gradient pulse length (δ) of 1 ms and 16 gradients ranging from 
2% to 95% of the maximum gradient (53 G/cm).
Nuclear magnetic relaxation dispersion (NMRD) profiles 
reporting the longitudinal relaxation rates of water protons (R1) 
over a magnetic field range from 0.25 mT to 0.94 T (0.015 - 40 
MHz proton resonance frequency) were recorded on a Fast 
Field Cycling (FFC) relaxometer (Stelar, Mede, Italy). The 
apparent saturation magnetization (MSNMRD), the Néel 
relaxation time (τN) and size of superparamagnetic crystal 
(DNMRD) were determined by fitting these NMRD curves 
numerically with the MINUIT minimisation program within the 
frame of the Outer Sphere relaxation model and a standard 
phenomenological approximation [40]. Additional longitudinal 
(T1) and transverse (T2) relaxation times were measured at 37°C 
on Bruker Minispec mq20 and mq60 relaxometers working 
respectively at 20 MHz (0.47 T) and 60 MHz (1.41 T). The 
diamagnetic contributions of THF to the relaxation rates at 37°C 
are R1 = 0.2759 s-1 and R2 = 0.2984 s-1 at 20 MHz and R1 = 0.2227 
s-1 and R2= 1.4837 s-1 at 60 MHz.
Results and discussion
Characterization and self-assembly of PEO45-b-PCL111 copolymer.
A copolymer of PEO-b-PCL was synthesized by ring opening 
polymerization of ɛ-CL monomer initiated by PEO chains with 
Mn of 2000 gmol-1 possessing two different end-groups, 
respectively –CH3 and –OH. The chemical structure of PEO-b-
PCL copolymer was assessed by 1H NMR spectroscopy. The 1H 
NMR spectrum shows typical peaks of PEO-b-PCL copolymers, 
whose integral intensities were used to determine the 
composition of the PEO-b-PCL copolymer (Fig. S1a in supporting 
information). The final block copolymer composition is PEO45-b-
PCL111, where 45 and 111 are the respective average degrees of 
polymerization (DP) of each monomer unit.  This composition is 
close to the target hydrophilic ratio (14% weight fraction) of 
PEO45-b-PCL105, which was chosen owing to its tendency to form 
a vesicular morphology [29, 30, 32, 34, 35, 37]. The copolymer 
is characterized by a relatively wide molecular weight dispersity 
(Ð=Mw/Mn = 1.35) as indicated by GPC (Fig. S1b in supporting 
information). In this work, we opted for a fast, efficient and easy 
to implement method for the formation of the nano-
assemblies, i.e. by the solvent shift method, also called 
nanoprecipitation. Sequential extrusions at 60°C (i.e. above the 
melting curve of PCL) through 1 µm, 0.8 µm, 0.4 µm and 0.2 µm 
pore size filters were necessary to narrow the size distribution 
(Fig. 1). TEM experiments (Fig. S3 in supporting information) 
confirm the formation of 60 nm diameter spherical 
nanostructures, suggesting thus the formation of the expected 
vesicles.
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Figure 1. Intensity-weighted size distributions of PEO45-b-PCL111 suspensions 
obtained by the nanoprecipitation method before (empty circles) and after (filled 
circles) extrusions through 1 µm to 0.2 µm pore size filters.
SANS experiments were performed on PEO45-b-PCL111 self-
assemblies in order to confirm their vesicular structures and 
estimate their membrane thicknesses. SANS curves were fitted 
with the vesicle (shell) form factor thanks to SASView software.  
The values obtained from the fitting are Rin = 84 nm and d = 17 
nm, where Rin corresponds to the inner aqueous compartment 
radius and d to the membrane thickness (the radius of the 
vesicle Rtot, is given by: Rtot = Rin + d). One can note that radii and 
thickness values calculated by fitting the SANS curves exhibit 
broad dispersity parameters  (no unit),e as samples analysed 
by SANS were not extruded to avoid sample loss on the filters 
as SANS analysis requires concentrated enough samples, in this 
case 6.2 mgmL-1). The I(q) curves computed using a hollow 
spherical shell model are well superimposed on experimental 
data, supporting the assumption that nano-vesicles are formed 
through the self-assembly of PEO45-b-PCL111 copolymers (Fig. 2).
In the intermediate range of scattering vectors, the neutron 
scattering intensities vary as q-2, this scaling law being 
characteristic of vesicular structures that exhibit locally planar 
morphology. The Kratky-Porod plot (ln [I(q)q²] versus q²) 
enables accessing the membrane thickness (d) with more 
robustness than a fit thanks to the following asymptotic law 
[45]:
        (2)ln [𝐼(𝑞)𝑞2]≅(
―𝑞²𝑑²
12 )
Ln [I(q)q²] plotted versus q² in figure 2 enables deducing a 
membrane thickness of 21 nm from the slope. Noteworthy, a 
membrane thickness of 22.5 nm was reported for PEO45-b-
PCL105 vesicles in the literature (measured by cryo-TEM analysis) 
[29], in good agreement with the value determined by SANS in 
the present study. The critical aggregation concentration (CAC) 
of PEO45-b-PCL111 copolymer in aqueous medium was 
determined by the fluorescence technique using pyrene as a 
probe sensitive to a nonpolar environment (at fixed 
concentration of 0.6 µM). As the block copolymer concentration 
increases, a shift of the band from 331 to 336 nm was observed: 
then by plotting the I336/I331 ratio (from the excitation spectra) 
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against the logarithm of the concentration (Fig. S2 in supporting 
information) a break is observed corresponding to the value of 
log (CAC). This low CAC value of 1.4 µgmL-1 indicates a good 
stability of PEO45-b-PCL111 vesicles upon dilution.
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Figure 2. SANS curves of PEO45-b-PCL111 vesicles: experimental data are plotted as open 
circles while solid lines represent the simulated intensity considering the form factor of 
hollow spheres with log-normal distributions on both Rin and d, whose standard values 
() are indicated. The insets shows the representation of ln[I(q)q²] versus q² calculated 
from SANS measurements in the Kratky-Porod regime giving a membrane thickness of 
21 nm.
Characterization of iron oxide nanoparticles.
Iron oxide nanoparticles having two different sizes (4.2 nm and 
7.6 nm) were synthesised by the thermal decomposition 
method. Narrow size distributions typical of this synthesis 
procedure were obtained. TEM images of USPIO were used to 
determine the size distribution of the magnetic cores (Fig. 3). 
The average diameters (DTEM) and the polydispersity index 
(PDITEM) extracted from a statistical treatment of sizes 
measured on TEM images as well as hydrodynamic diameters 
(DH) and PDI measured by DLS (PDIDLS) using the 2nd order 
Cumulant fit of correlograms are reported in Table 1. NMRD 
profiles which display the evolution of proton longitudinal 
relaxivity r1 as a function of the applied field (or the 
corresponding proton resonance frequency) were recorded on 
these two samples (Fig. S4 in supporting information). These 
profiles were fitted using the usual Outer Sphere theory 
modelling the acceleration of proton relaxation induced by 
superparamagnetic NPs [44] applied to suspensions in THF, for 
which a molecular diffusion coefficient of 3.27 10-9 cm2s-1 at 
37°C has been measured independently by diffusion-ordered 
NMR spectroscopy (DOSY). Table 1 shows the values of the 
relaxometric Outer Sphere diameter (DNMRD), which represents 
the shortest distance between the centre of the magnetic core 
of the USPIOs and the THF molecules, together with their 
apparent saturation magnetization (MsNMRD) values that are 
almost identical ( 50 Am2kg-1) for both samples.
Table 1. Physicochemical characteristics of the USPIOs synthesised by the thermal decomposition method: diameter measured by TEM, DLS, NMRD, saturation magnetization 
(MsNMRD) and Néel relaxation time (τN) extracted from the fits of NMRD profiles.
Sample DTEM (nm) PDITEM DH (nm) PDIDLS DNMRD (nm) MsNMRD (Am²kg-1) τN (ns)
7.6 nm USPIO 7.6 0.14 11.8 0.05 8.5 49.4 2.24
4.2 nm USPIO 4.2 0.08 8.4 0.03 5.6 49.7 2.69
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Figure 3. TEM images and histogram of diameters of USPIO synthesized by the thermal decomposition method: (a) USPIO with DTEM =  7.6 nm (7.6 ± 1.6 nm, PDITEM = 0.14) and (b) 
USPIO with DTEM = 4.2 nm (4.2 ± 0.5 nm, PDITEM = 0.08). PDI values are defined by Eq. (1). 
Longitudinal (r1) and transverse (r2) relaxivities were measured 
in THF (37°C) at 20 and 60 MHz. Iron oxide nanoparticles with 
larger diameters possess higher longitudinal and transverse 
relaxivities and higher transverse to longitudinal relaxivity 
ratios, while staying at low values (r2/r1 below 3) typical for 
small and well-dispersed (un-aggregated) USPIOs  (Table 2).
Table 2. USPIO’s longitudinal and transverse relaxivities 
measured at 20 and 60 MHz (in THF and 37°C) and resultant r2/r1 
ratios.
Sample Frequency 
(MHz)
r1 (s-1 mM-1) r2 (s-1mM-1) r2/r1
7.6 nm 
USPIO
20
60 
21.9
12.8
36.6
37.7
1.7
2.9
4.2 nm 
USPIO
20
60
8.6
7.8
12.1
17.9
1.4
2.3
Formulation and characterization of USPIO loaded in PEO45-b-PCL111 
polymersomes
Nanoprecipitation of PEO45-b-PCL111 co-assembled with iron 
oxide nanoparticles was performed by varying the initial USPIO 
concentration at constant copolymer concentration, the ratio of 
their weight concentrations in THF being defined as the “feed 
weight ratio” (FWR). After adjustment, the best results were 
obtained by mixing 10 mg of the block copolymer with 500 μL 
of THF containing USPIOs at concentrations close to [Fe]0 ~ 40 
mM for 7.6 nm USPIO and [Fe]0 ~ 80 mM for 4.2 nm USPIO. The 
corresponding FWR values are respectively 16% and 32%, 
within the same range as in the study by Arosio et al. [46] with 
another amphiphilic copolymer also forming vesicles. Above 
these threshold values, no more USPIOs could be entrapped in 
the vesicle membranes and large aggregates of USPIOs were 
observed by mere visual inspection. The TEM image of the 
sample obtained by nanoprecipitation of PEO45-b-PCL111 loaded 
at 16% FWR with 7.6 nm USPIO shows spherical structures with 
a high USPIO content as well as some filamentous fragments 
connected to some of the spheres certainly formed during the 
drying step of the TEM grid preparation (Fig. 4a). To confirm 
that these fragments arise from the destruction of spherical 
structures during the drying step, cryo-TEM imaging allowing 
the visualization of colloids in the frozen-hydrated state was 
performed. As expected, only spherical structures were 
observed (Fig. 4b). However, it can be noted that these 
spherical structures are arranged into chain-like aggregates, 
which could be an artefact due to their accumulation within the 
wedge of the ultrathin frozen film near a border of the TEM grid 
(being sterically excluded from the centre of the film because 
its thickness becomes smaller than vesicles diameter). The 
absence of clusters in the liquid suspensions is confirmed by 
dynamic light scattering measurements showing a monomodal 
size distribution with a mean hydrodynamic diameter close to 
130 nm (DH = 129 nm, PDIDLS = 0.13) (Fig. 4c), characteristic of 
well-defined and individually dispersed objects.
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Figure 4. Size and morphology of PEO45-b-PCL111 vesicles loaded at FWR=16% with USPIO 
nanoparticles of 7.6 nm diameter. (a) Low magnification TEM image showing intact 
spherical structures as well as some fragments (scale bar = 500 nm). (b) Cryo-TEM image 
showing only spherical structures (scale bar = 100 nm). (c) Intensity-weighted size 
distribution measured by DLS (DH = 129 nm, PDIDLS = 0.13).
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Nanoprecipitation of PEO45-b-PCL111 loaded at 32% FWR 
with 4.2 nm USPIO gave similar results. Spherical structures 
exhibiting a high USPIO content were observed on the TEM 
images (Fig. S4a in supporting information). A mean 
hydrodynamic diameter of 146 nm (PDIDLS = 0.10) was measured 
by DLS (the intensity-weighted size distribution is given in Fig. 
S4b). Concerning vesicle stability on time, the size distribution 
of magnetovesicles did not change significantly after storage for 
one month at 4°C. Multi-angle dynamic (DLS) and static (SLS) 
light scattering measurements were conducted on 
nanoprecipitated samples obtained by co-assembly of PEO45-b-
PCL111 with USPIOs of both sizes. Mean values of the radius of 
gyration (RG), aggregate weight-averaged molar mass (Mwagg) 
and aggregation number, i.e. the number of macromolecules 
per aggregates (Z), were determined from SLS measurements 
upon drawing Guinier and Berry plots (at several weight 
concentrations and over a scattering angular range of 40-140°). 
These plots are provided in Supporting Information (Fig. S5 and 
Fig. S6). The determination of the refractive index increment dn/dc 
as measured using a RI detector for GPC was required to determine 
the molar masses of the self-assembled nanostructures. Resulting 
dn/dc values were 0.102 Lg-1 for PEO45-b-PCL111 loaded at 16% FWR 
with 7.6 nm USPIOs and 0.147 Lg-1 for PEO45-b-PCL111 loaded at 32% 
FWR with 4.2 nm USPIOs. Such increase of the RI increment when 
inorganic NPs like USPIOs (whose RI is 2.3) are embedded in the 
objects was predictable. As the mean value hydrodynamic radius can 
depend on the scattering angle used for the measurement (as 
ascribed to size dispersity), multi-angle DLS measurements were 
performed over the same scattering angle range to measure the 
angle-average hydrodynamic radius (RH). From these measurements, 
one can calculate the ratio ρ = RG/RH, which enables to estimate the 
morphology of the self-assembly nanostructures: vesicles are 
characterized by ρ values close to 1 while ρ values around 
√(3⁄5)≈0.775 are expected for spherical micelles [47, 48]. In the 
present study, the ρ values calculated from the experimental multi-
angle DLS and SLS results are in good agreement with vesicular 
structures (Table 3). Although they appear a bit higher, the Z values 
 5-7104 calculated for the aggregation numbers of copolymers 
(after subtracting the fraction of mass of iron oxide in the objects) 
are also in agreement with values Z  3104 reported by Adams et al. 
[26] for polymersomes made of PEO45-b-PCL101. In conclusion, 
nano-objets produced by the self-assembly of PEO45-b-PCL111 
with hydrophobically coated USPIOs are vesicles possessing a 
diameter close to 160-180 nm. These nanoprecipitated objects 
remain of vesicular morphology, despite their high USPIO 
payload (16 or 32% FWR) that can fit within the thick 
hydrophobic membranes.
Table 3. Structural characteristics of PEO45-b-PCL111 magnetovesicles measured by multi-
angle DLS and SLS measurements: Hydrodynamic radius RH measured by decay rate plots 
vs. square of scattering vector (Fig. S5a,b), radius of gyration RG measured from Guinier 
plots (Fig. S6a,b), molar mass of scatterers Mwagg and aggregation number 
Z=Mwagg/(1+FWR)/Mwpolymer of the constituting macromolecules deduced from Berry 
plots (Fig. S6c,d).
Sample RH 
(nm)
RG 
(nm)
ρ = RG/RH Mwagg 
(gmol-1)
Z
PEO45-b-PCL111
+7.6 nm USPIO 
at 16% FWR 
92.0 89.2 0.97 1.9 109 7104
PEO45-b-PCL111
+ 4.2 nm USPIO 
at 32% FWR 
90.3 81.5 0.91 1.7 109 5104
Relaxometric properties of USPIOs loaded in PEO45-b-PCL111 
vesicles.
An MRI contrast agent is a magnetic compound that alters 
the signal intensity of specific parts on MR images by shortening 
longitudinal relaxation time (T1) and transverse relaxation time 
(T2) of water protons in the biological tissues. The efficiency of 
an MRI contrast agent is quantified in vitro by its longitudinal 
and transverse relaxivities (r1 and r2), which reflect the ability of 
the contrast agent to decrease T1 and T2 relaxation times of the 
water protons, respectively. In particular, T2-weighted contrast 
agents decrease MRI signal intensity and thus darken regions 
where they accumulate (while those where they are absent, like 
a liver tumour, appear brighter). The most effective T2-weighted 
contrast agents are those characterized by the highest r2/r1 
ratio. USPIOs can also be used as T1-contrast agents, but only as 
long as their r2/r1 ratio remains at a value lower than 3, typically 
[49]. Relaxometry studies were performed on magnetic 
polymersomes loaded with two different size and loading 
contents of USPIOs, namely at 32% FWR with those of 4.2 nm 
diameter and 16 % FWR for the 7.6 nm diameter ones. 
Relaxation rates 1/T1 (s-1) and 1/T2 (s-1) were measured at 20 
and 60 MHz (37°C) at different iron concentrations (mM). The 
plots of the relaxation rates versus equivalent iron 
concentration are given in Fig. 5. Longitudinal and transverse 
relaxivities deduced from the slopes are reported in Table 4. 
Encapsulation of USPIOs into the hydrophobic membranes of 
PEO45-b-PCL111 polymersomes leads to a significant decrease of 
r1 (due to a reduced accessibility of water protons to USPIO 
surface), and an increase of r2 (due to USPIO clustering into the 
vesicle) compared to USPIOs individually dispersed in the 
solvent (see r1 and r2 values in THF in Table 2). In addition, it is 
well-known in the literature of MRI contrast agents [50] that r1 
decreases as a function of the applied magnetic field while r2 
reaches a plateau value. Consequently, higher transverse to 
longitudinal relaxivity ratios (r2/r1) were obtained at 60 MHz 
compared to those at 20 MHz.
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Table 4. Longitudinal (r1) and transverse (r2) relaxivities (in water and at 37°C) and 
resulting r2/r1 ratios of USPIO loaded in PEO45-b-PCL111 vesicle membranes.
Sample Frequency 
(MHz)
r1 
(s-1mM-1)
r2 
(s-1mM-1)
r2/r1
PEO45-b-PCL111 + 
7.6 nm USPIO at 
16% FWR
20
60 
3.3
1.3
187
197
57
154
PEO45-b-PCL111 + 
4.2 nm USPIO at 
32% FWR
20
60
0.6
0.3
109
110
171
389
As already reported in the literature for vesicles made from 
other copolymers, higher transverse relaxivities were obtained 
for polymersomes loaded with larger USPIOs [14, 46]. In this 
work, polymer vesicles loaded at 16% FWR with 7.6 nm USPIO 
have a transverse relaxivity of 197 s-1mM-1 (60 MHz) while 
those loaded at 32% FWR with 4.2 nm USPIO have a smaller 
transverse relaxivity of 110 s-1mM-1 (60 MHz). Interestingly, 
polymersomes loaded with 4.2 nm exhibit significantly lower 
longitudinal relaxivities:  r1 = 0.3 s-1mM-1 at 60 MHz compared 
to r1 = 1.3 s-1mM-1 for vesicles loaded with 7.6 nm USPIOs. 
This can be explained by their total embedding within the 
hydrophobic PCL blocks of the membranes (of thickness 21 nm 
according to SANS, much larger than 4.2 nm), thereby avoiding 
any direct contact of the water molecules with the iron oxide 
surface (thus preventing the contribution of the so-called “Inner 
Sphere” mechanism [50] to proton relaxations). Therefore even 
higher transverse to longitudinal relaxivity ratios (r2/r1) were 
obtained for vesicles loaded with smaller USPIOs compared to 
the larger ones, thereby demonstrating their high potential as 
T2-contrast agents despite their lower transverse relaxivity, 
however that is analogous to the one of commercial SPIO MRI 
contrast agents.
NMRD profiles were recorded on polymersomes loaded 
with USPIOs possessing a diameter of 4.2 nm at 32% FWR and 
7.6 nm at 16% FWR (Fig. S7 in supporting information). One can 
clearly note that longitudinal relaxivities of polymer vesicles 
loaded with the smallest USPIO (4.2 nm USPIO) are lower than 
those of vesicles loaded with largest USPIO (7.6 nm USPIO) over 
the whole range of measured frequencies. Compared to the 
NMRD profiles of individual USPIOs in THF (Fig. S4), a shift of the 
maxima towards lower Larmor frequencies were observed, and 
became more pronounced when the diameter of incorporated 
USPIOs was larger. A similar shift was already reported for PGA-
b-PTMC vesicles incorporating USPIOs of different sizes [46] and 
ascribed to their embedding in the membranes, making them 
behave as aggregates of larger size than individually dispersed 
USPIOs.
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Figure 5. Relaxations rates as a function of iron concentration (mM) for PEO45-b-PCL111 vesicles loaded with iron oxides nanoparticles: (a) 1/T2 (s-1) for vesicles loaded at 16% FWR 
with 7.6 nm USPIOs: slopes and intercepts are r2=186 s-1mM-1 and R20=0.506 s-1 at 20MHz, r2=198 s-1mM-1 and R20=1.54 s-1 at 60MHz. (b) 1/T1 (s-1) for vesicles loaded with 7.6 nm 
USPIOs at 16% FWR: slopes and intercepts are r1=3.14 s-1mM-1 and R10=0.28 s-1 at 20MHz, r1=1.19 s-1mM-1 and R10=0.26 s-1 at 60MHz. (c) 1/T2 (s-1) for vesicles loaded with 4.2 nm 
USPIOs at 32% FWR: slopes and intercepts are r2=110 s-1mM-1 and R20=0.506 s-1 at 20MHz, r2=119 s-1mM-1 and R20=1.54 s-1 at 60MHz. (d) 1/T1 (s-1) for vesicles loaded with 4.2 nm 
USPIOs at 32% FWR: slopes and intercepts are r1=0.638 s-1mM-1 and R10=0.24 s-1 at 20MHz, r1=0.283 s-1mM-1 and R10=0.235 s-1 at 60MHz
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In addition, the inflection points observed at low fields (below 1 
MHz) on the NMRD profiles of individual USPIOs, usually 
ascribed to Néel relaxation of the moments, are absent on the 
NMRD profiles of the magnetic vesicles. These were fitted using 
the usual “Outer Sphere” model for superparamagnetic MRI 
contrast agents. Parameters extracted from these fittings 
(DNMRD and MSNMRD) are reported in Table S1 (supporting 
information). Compared to individually dispersed USPIOs, an 
increase of DNMRD and a decrease of MSNMRD were observed. 
These results are in agreement with the presence of a 
hydrophobic polymer layer surrounding the nanoparticles, 
preventing water molecules to approach surface of the 
magnetic centre (thus avoiding any Inner Sphere contribution 
to proton relaxation). The decreased magnetization values can 
be easily understood by the dilution of the magnetic iron oxide 
within the non-magnetic phase. It is also very interesting to note 
that the values of “Outer Sphere” diameters DNMRD deduced 
from the fits are nearly equal to the hydrophobic membrane 
thickness measured by SANS (20.8 nm for 7.6 nm USPIOs at 16% 
FWR and 18.2 nm for 4.2 nm ones at 32% FWR). This parameter 
deduced by relaxometric experiments corresponds to a 
characteristic distance on which the presence of water 
molecules is forbidden, thus it is equal to the membrane 
hydrophobic thickness as from SANS and TEM.  
In addition to their use as MRI contrast agents, magneto-
vesicles described in the present study can also be used for 
magnetic separation, as they are retained by a LS column™ 
placed in an electromagnet, which confirms their high USPIO 
content. A study reported that magneto-liposomes containing a 
low amount of ferrofluid are not retained on the same magnetic 
column [51]. Size distributions (Fig. S8), TEM images (Fig. S9) 
and proton NMR relaxivities (Table S2 in supporting 
information) before and after magnetic chromatography are 
similar, which suggests that the samples are not affected by the 
magnetic chromatography and can therefore be concentrated 
by this method. Magnetophoretic separation can also be used 
to purify the sample and change the external aqueous medium, 
after loading with a hydrosoluble drug such as doxorubicin for 
example [52].
Degradation of USPIO loaded in PEO45-b-PCL111 vesicles in acidic 
aqueous conditions.
The degradation of PEO45-b-PCL111 based magneto-
polymersomes (encapsulating 7.6 nm USPIOs at 16% FWR) was 
studied in weakly acidic conditions, mimicking biologically 
relevant conditions as tumour environment or intra-lysosomal 
location after cell uptake. It is indeed known that hydrolysis of 
polyesters shortens hydrophobic blocks and consequently 
increases the hydrophilic mass fraction of block copolymer 
chains. Such degraded chains with comparatively short 
hydrophobic blocks will perturb local bilayer curvature and 
induce the growth of pores in polymersome membranes [29, 
53-55]. Poration of polyester membranes at acidic pH is 
particularly interesting for drug delivery purpose as it can 
induce drug release from polymersomes uptaken by biological 
cells through an endocytosis pathway that end up in acidic (pH 
around 5) lysosomal compartments [29, 54]. 
To evaluate if the overall structure is affected or not by the 
acidic pH, GPC, DLS and TEM measurements performed at pH 7 
were compared to the results obtained at weakly acidic pH (pH 
5) after 7 days. The TEM images of the sample left 7 days at pH
7 and 37°C are similar to those of the sample left at pH 5 and 
37°C. Spherical nanostructures with a high USPIO content as 
well as some filamentous fragments were observed (Fig. S10a 
and Fig. S10b in supporting information). DLS measurements 
also show similar size distributions (sample left at pH 7 and at 
pH 5) with mean hydrodynamic diameters in the range between 
130 and 150 nm and PDIDLS values smaller than 0.17 (Fig. S10c 
and Fig. S10d in supporting information). This suggests that 
spherical structures loaded with iron oxide nanoparticles were 
still present in the suspensions even after one week (168 
hours) at 37°C and pH 5.
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Figure 6. Longitudinal relaxivities (a), transverse relaxivities (b) and transverse to 
longitudinal relaxivity ratios (c) at 60 MHz for PEO45-b-PCL111 vesicles loaded at 16% 
FWR with 7.6 nm USPIOs at pH 7 (red filled markers) and pH 5 (blue empty markers) as 
a function of time.
In parallel, the relaxivities of polymer vesicles loaded at 16% 
FWR with 7.6 nm USPIO were measured over time at two 
different pH (pH 7 and pH 5). Figure 6 shows results obtained at 
60 MHz. Similar trends were observed at 20 MHz as shown in 
supporting information (Fig. S11). At pH 7 and at 37°C, 
longitudinal and transverse relaxivities did not vary significantly 
during the studied period (7 days). On the contrary, at pH 5, the 
longitudinal relaxivity increases abruptly and the transverse 
relaxivity decreases more continuously over time, which results 
in an sigmoid decrease of the transverse to longitudinal 
relaxivity ratio (r2/r1), with a jump occurring after 2 days of 
sample acidolysis. These relaxivity variations can be interpreted 
by the formation of hydrophilic pores in the PCL membranes 
occurring as the hydrophobic PCL block is progressively 
hydrolysed [25, 50, 51]. Water molecules could pass through 
PCL membrane leading to an increase of r1 (due to an increased 
accessibility of water protons directly to the USPIO surface) and 
a decrease of r2 (due to a reduced USPIO clustering effect). Such 
polymer degradation has been further highlighted by GPC for 
empty vesicles (Fig. 7), for which we could notice the 
appearance of a second peak at higher retention time 
corresponding to a Mn  2600 gmol-1, and attributable to PEG 
chains liberated in the medium, presumably still joined to a 
much degraded PCL block.
Figure 7. GPC traces in THF (RI detector) of the copolymer dissolved in two different 
buffers (pH7.4 and pH5.2) after dialysis, freeze-drying and recovery in THF at different 
times. The main peak around an elution volume of 20 mL correspond to following molar 
masses expressed relatively to the PS standard curve: Mn=12000 g·mol-1 and Mw= 15700 
g·mol-1 at t=0;, Mn=11700 g·mol-1 and Mw= 15800 g·mol-1 at t=24h (pH5; flashy green 
curve); Mn=12300 g·mol-1 and Mw= 16200 g·mol-1 at t=72h (pH5; blue curve); Mn=12600 
g·mol-1 and Mw= 16500 g·mol-1 at t=144h (pH5; pink curve); Mn=12400 g·mol-1 and Mw= 
17000 g·mol-1 at t=168h (pH5; black curve); Mn=12800 g·mol-1 and Mw= 16600 g·mol-1 at 
t=208h (pH5; dark green curve); Mn=12100 g·mol-1 and Mw= 16000 g·mol-1 at t=208h 
(pH7). After 72h at pH5, a second peak appeared around 24 mL, corresponding to 
Mn=2600 g·mol-1 and Mw= 2700 g·mol-1.  This secondary peak represent 1.6% of the total 
weight at t=72h (assuming identical refraction index increments), increasing to 8% at 
t=144h until reaching a plateau at 11% for t=168h. This peak is also present, yet at lower 
extent (3% of total weight) after 208h at pH7 (red curve), and can be ascribed to PEG 2kD 
chains linked to a much degraded PCL block. 
This peak appeared 72 hours (3 days) after incubation at 
pH5.2, and was also observable, at lower extent,  after 208 
hours at pH7.4. This result confirms the slow acidolysis of the 
PCL blocks. Although the vesicles did not show any sign of 
disruption neither by TEM nor DLS, their relaxometric data 
proved access of the water molecules to the USPIO surfaces, 
thus enhanced permeability of the membranes after only 2 days 
at pH5. This MRI response is even more sensitive than by 
measuring molecular dimension of the chains by GPC, which 
showed clear evidence of chain cleavage, but only after 3 days 
at pH5.2.      
In future in vivo experiments, such variations of r1 and r2 
could be turned into a greater advantage to monitor 
experimentally the PCL degradation in the membrane drug-
nanocarriers from the modulation of the contrast of MR images 
and correlate the evidenced drug release with anatomic 
information (e.g. tumour volume). An enhanced MRI contrast 
following a controlled drug release and accumulation to 
diseased organs/tissues is very promising for in vivo applications 
[56, 57].
In previous literature, D. Hammer et al. showed that 
hydrolytic degradation of PEO-b-PCL vesicles incorporating 
porphyrin-based fluorophores within the PCL core results in 
change in porphyrin emission providing a powerful tool for 
monitoring in vivo drug delivery non-invasively [34]. Such 
degradative mechanism of polyester-made vesicles, catalysed 
by enzymes, was also reported in recent work by Zhu et al. [58]. 
However, to the authors’ knowledge, no similar work using MRI 
contrast agents to monitor degradation of polyesters like PCL in 
membranes was never reported. The novelty of our work stands 
in the proof that this phenomenon strongly influences the MRI 
contrasting properties. To show the interest of PEO45-b-PCL111 
vesicles loaded with USPIOs for monitoring degradation of PCL 
membrane of nanovesicles in vivo, we computed the signal 
levels by the approximated solution of Bloch equations, a 
method that we used in a precedent study [49] to predict the 
evolution of MR image contrast from proton NMR relaxometric 
measurements:
(3) 1 2/ /MRI H 1 TR T TE TS e e    
Where SMRI corresponds to the theoretical MRI signal intensity, 
ρH corresponds to the proton volume density, TR is the 
repetition time and TE is the echo time.
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Figure 8. Theoretical predictions of MRI signal levels computed using Eqn (3) with 
the experimental values of T1, T2, TE and TR for water (green triangular filled 
markers) and PEO45-b-PCL111 vesicles loaded at 16% FWR with 7.6 nm USPIO at pH 
7 (red circular filled markers) and pH 5 (blue circular empty markers) as a function 
of time.
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The SMRI calculated with experimental T1 and T2 are represented 
for a T2-weighted sequence (TR = 300 ms, TE = 12 ms) on Fig. 8, 
and their numerical values are provided on Table 5. At pH 7, SMRI 
does not change significantly with time. On the contrary, SMRI 
increases with time at pH 5 due to hydrolytic degradation of PCL 
membrane resulting in an increase of r1 and a decrease of r2. 
Again, the interest of these magnetic nano-vesicles made of a 
hydrolysable copolymer is evidenced, by the predicted positive 
contrast enhancement of MRI signal. 
Table 5. Longitudinal (T1) and transverse (T2) proton relaxation times for PEO45-b-
PCL111 vesicles loaded with 16 wt.% 7.6 nm USPIOs measured at 60 MHz (37°C) at 
pH 5 and pH 7 and resulting SMRI calculated from Eqn (3) for a T2-weighted 
sequence (TR = 300 ms, TE = 12 ms).
pH 7 pH 5
Time 
(hours)
T1 (ms) T2 
(ms)
SMRI T1 
(ms)
T2 
(ms)
SMRI
0
28
52
71
78
95
167
986
986
978
998.5
1002
1017.5
998.5
7.84
8.23
8.32
8.55
8.75
9.14
9.42
0.057
0.061
0.062
0.064
0.066
0.069
0.073
1093
1080
1062
864
856
877
887
9.16
9.66
10.88
12.98
13.70
16.29
18.74
0.065
0.070
0.081
0.116
0.123
0.139
0.151
Conclusions
Iron oxide nanoparticles possessing two different sizes (DTEM = 
4.2±0.5 nm and DTEM = 7.6±1.6 nm) were produced by the 
thermal decomposition method of iron(acac)3 precursor. These 
hydrophobically-coated USPIO nanoparticles were easily 
incorporated into PEO45-b-PCL111 vesicles by a 
nanoprecipitation method at maximal feed weight ratios (FWR) 
of 32% and 16%, respectively. Extrusion cycles were performed 
to produce vesicles around 150 – 180 nm in diameter with a 
narrow size distribution, ideal for in vivo applications, including 
systemic injection. In addition to their biocompatible and 
biodegradable composition, vesicles possess PEO chains on 
their surface which are known to confer “stealth” properties to 
the nanoparticles in vivo, i.e. a prolonged half-life (long T1/2) in 
the blood circulation that is a prerequisite for an efficient drug 
delivery system.
Magnetic polymeric vesicles with high USPIO contents were 
obtained by optimizing the initial FWR. These magneto-
polymersomes show good MRI contrasting properties at 20 and 
at 60 MHz, the second resonance frequency being close to the 
one in the field of most MRI scanners used in clinics. They are 
characterized by very high transverse-to-longitudinal relaxivity 
ratios (r2/r1), which demonstrates that they are very promising 
candidates as T2-contrast agents for at least pre-clinical studies. 
Relaxivities of polymer vesicles embedded with USPIO 
possessing two different sizes were compared. Results 
confirmed that magneto-polymersomes incorporating larger 
USPIOs possess higher transverse relaxivity (yet at a lower 
FWR). We showed that the size of the embedded USPIOs plays 
also a critical role on the longitudinal relaxivity: PEO45-b-PCL111 
polymersomes loaded at 32% FWR with 4.2 nm USPIO possess 
significantly lower longitudinal relaxivities and higher r2 to r1 
ratios than vesicles loaded with 7.6 nm USPIOs at 16% FWR, 
which was interpreted by the total embedding of the USPIOs 
within the membranes (none of them being located near the 
hydrated PEG blocks of the copolymer).  
Relaxometry studies at pH 5 vs pH 7, combined with a 
complementary test of copolymer chain degradation by GPC, 
confirm the formation of pores in PCL membrane in acidic 
conditions. These findings demonstrate the huge potential of 
the magneto-polymersomes described in the present study as 
drug delivery systems with image-control by MRI of the 
sustained release of encapsulated therapeutics in weakly acidic 
media such as tumours and intracellular endo/lysosomal 
compartments. Variations of r1 and r2 relaxivities along the PCL 
hydrolysis illustrate that these superparamagnetic PEO45-b-
PCL111 vesicles are promising pH-sensitive MRI contrast agents 
enabling to track the PCL chain degradation accompanying the 
delivery of pre-encapsulated species in vivo.
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Determination of the composition of PEO-b-PCL copolymer by 1H NMR
1H NMR spectrum of PEO-b-PCL copolymer was recorded at 500 MHz in CDCl3 (Fig. S1). 
The peak at 3.65 ppm is attributed to the methylene protons of the ethylene oxide units of PEO 
(protons B + B’). The peak corresponding to two protons of the last EO unit connected to PCL 
block (protons C) is lost in the background noise. As the average number of EO units is 45 (the 
synthesis was performed with PEO possessing an average molecular weight of 2000 g/mol), 
the integral intensity of the signal at 3.65 ppm (protons B and B’) was set to 178. 
Methylene protons of the ε-caprolactone units of PCL segment appeared as four signals at 4.07 
ppm, 2.32 ppm, 1.65 ppm and 1.40 ppm as marked in figure S1. A degree of polymerization of 
PCL block (DPCL) equal to 111 was determined from the integral intensity of the well-resolved 
peak at 4.07 ppm (I4.07 ppm) according to the equation S.1. The peak corresponding to two 
protons of the last CL unit connected to the hydroxyl group (protons H) is lost in the background 
noise.  
DPCL = (I4.07 ppm  + 2) / 2 (S.1)
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Figure S1. (a) 500 MHz 1H NMR spectrum of PEO45-b-PCL111 copolymer in CDCl3 ; (b) GPC 
chromatogram of PEO45-b-PCL111 obtained in THF (only UV and RI detector signals are plotted, the 
flow marker peak at 32.6 min being ascribed to 1,2,4-trichlorobenzene added in the eluent). The 
copolymer molar mass dispersity deduced is Ð=Mw/Mn=1.35.
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Figure S2. Plot of the I336/I331 ratio against the logarithm of concentration of PEO45-b-PCL111 
suspensions in the presence of pyrene at fixed concentration of 0.6 µM.
Figure S3. TEM images of PEO45-b–PCL111 polymersomes negatively stained with uranyl acetate 
(scale bar = 200 nm)
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Figure S4. NMRD profiles of the longitudinal relaxivity vs. proton Larmor resonance frequency at 
37°C for (a) 7.6 nm and (b) 4.2 nm USPIOs in THF. The fitting parameters are given in Table 1.
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Figure S5. Size and morphology of PEO45-b-PCL111 vesicles loaded at 32% FWR with iron oxide 
nanoparticles of 4.2 nm diameter. (a) Low magnification TEM image showing vesicles with a high 
payload of USPIO (scale bar = 500 nm). The inset shows a close-up view of one vesicle (scale bar = 
100 nm). (b) Intensity-weighted size distribution measured by DLS (DH = 146 nm, PDIDLS = 0.10). 
         a)                                                                                b) 
q² (m-2)
0 2e+14 4e+14 6e+14
D
ec
ay
 ra
te
 (s
-1
)
0
200
400
600
800
1000
1200
1400
1600
1800
Experimental data
Linear fit
y = 2.6521e-12x - 88.3972
R² = 0.9989
q² (m-2)
0 2e+14 4e+14 6e+14
D
ec
ay
 ra
te
 (s
-1
)
0
200
400
600
800
1000
1200
1400
1600
1800
Experimental data
Linear fit
y = 2.7025 e-12x -95.78
R² = 0.9961
Figure S6. Multi-angle DLS plots: Variations of decay rate  versus squared scattering vector q2 
measured by multi-angle DLS by applying a CONTIN fit on a) Nanoprecipitated objects made by co-
assembly of PEO45-b-PCL111 with 7.6 nm USPIO at 16% FWR and at a concentration of 0.11 mgmL-1 
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and b) Nanoprecipitated objects by co-assembly of PEO45-b-PCL111 with 4.2 nm USPIO at 32% FWR 
and at a concentration of 0.052 mgmL-1. The slopes lead to the diffusion constants of the objects, 
respectively 2.65 10-12 m²/s-1 (a) and 2.70 10-12 m²/s-1 (b), from which the hydrodynamic radii are 
calculated using Stokes-Einstein’s equation, respectively 92.0 nm (a) and 90.3 nm (b).
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Figure S7. Multi-angle SLS plots:  Guinier (a,b) and Berry (c,d) plots on nanoprecipitated objects 
made by co-assembly of PEO45-b-PCL111 with 7.6 nm USPIOs at 16% FWR (a,c) or with 4.2 nm 
USPIOs at 32% FWR (b,d). Scattering angles were varied from 40° to 140° and concentrations from 
0.041mgmL-1 (for 4.2 nm USPIO sample) to 0.554 mgmL-1 (for 7.6 nm USPIO sample).
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Figure S8. NMRD profiles of the longitudinal relaxivity vs. proton Larmor resonance frequency at 
37°C for PEO45-b-PCL111 vesicles loaded at 16% FWR with 7.6 nm USPIOs (circles) and at 32% 
FWR of 4.2 nm USPIOs (squares). The solid lines correspond to the MC simulation based on the 
theoretical model for superparamagnetic contrast agents. 
Table S1. Parameters extracted from the fitted NMRD profiles (DNMRD and MSNMRD) of USPIOs 
loaded in PEO45-b-PCL111 vesicles (in water) and individually dispersed USPIOs (in THF). 
Sample DNMRD (nm) MSNMRD (Am²kg-1)
20.8 14.0PEO45-b -PCL111 vesicles + 7.6 nm USPIOs at 16% 
FWR (in water) 
8.5 49.47.6 nm USPIO (in THF)
18.2 5.6PEO45-b -PCL111 vesicles + 4.2 nm USPIOs at 32% 
FWR (in water) 
 4.2 nm USPIO (in THF) 5.6 49.7
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Figure S9. Intensity-weighted size distribution measured by DLS of PEO45-b-PCL111 vesicles 
measured after synthesis and after magnetic chromatography (a) vesicles loaded at 16% FWR with 
USPIOs of 7.6 nm diameter and (b) vesicles loaded at 32% FWR with USPIOs of 4.2 nm diameter.
      
Figure S10. TEM image of PEO45-b-PCL111 vesicles loaded at 16% FWR with iron oxide 
nanoparticles of 7.6 nm diameter after magnetic chromatography.
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Table S2. Longitudinal (r1) and transverse (r2) relaxivities (in water and at 37°C) and resultant r2/r1 
ratios of USPIO loaded in PEO45-b-PCL111 vesicles before and after magnetic chromatography
Before magnetic 
chromatography
After magnetic 
chromatography
Sample Larmor 
frequency 
(MHz)
r1 
(s-1mM-1)
r2 
(s-1mM-1)
r2/r1 r1 
(s-1mM-1)
r2
(s-1mM-1)
r2/r1
PEO45-b-PCL111 + 
USPIO 7.6 nm 
(FWR=16%)
20
60 
3.23
1.22
187
198
58
162
2.85
1.09
172
188
60
173
PEO45-b-PCL111+ 
USPIO 4.2 nm 
(FWR=32%)
20
60
0.64
0.28
109
110
171
389
0.55
0.23
94
87
171
371
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Figure S11. TEM images (a and b) and intensity-weighted size distributions (c and d) of PEO45-b-
PCL111 vesicles loaded at 16% FWR with 7.6 nm iron oxide nanoparticles: a) and c) sample left 7 days 
at 37°C and at pH 7 and b) and d) sample left 7 days at 37°C and at pH 5.
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Figure S12. Longitudinal relaxivities (a), transverse relaxivities (b) and transverse to longitudinal 
relaxivity ratios (c) at 20 MHz for PEO45-b-PCL111 vesicles loaded at 16% FWR with 7.6 nm USPIOs 
at pH 7 (red markers) and pH 5 (blue markers) as function of time.
